Matthew Doctor

CIK: 0001844838

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RGS

REGIS CORP

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

RGS
REGIS CORP
Nov 22, 2024
Award(A)
Direct
16.5K shares-
RGS
REGIS CORP
Nov 5, 2024
Tax Payment(F)
Direct
547 shares at avg. $23.37$13K
RGS
REGIS CORP
Nov 5, 2024
Tax Payment(F)
Direct
339 shares at avg. $23.37$8K

		Type	Shares	Price		Ownership
Nov 22, 2024	RGS REGIS CORP	Award(A)	16,500	-	$0	Direct
Nov 5, 2024	RGS REGIS CORP	Tax Payment(F)	547	$23.37	$12,783	Direct
Nov 5, 2024	RGS REGIS CORP	Tax Payment(F)	339	$23.37	$7,922	Direct

1-3 of 3 transactions

About Doctor Matthew

Doctor Matthew (SEC CIK 0001844838) files insider reports with the SEC as President and CEO of REGIS CORP (RGS).

Signal8 holds 3 ownership filings by Doctor Matthew, all Form 4s, filed between Nov 7, 2024 and Nov 26, 2024. Those filings report 3 transactions, from Nov 5, 2024 to Nov 22, 2024. Signal8's Form 4 history starts in Sep 2024.

The business address on Doctor Matthew's filings is in MINNEAPOLIS, MN.

Recent filings by Doctor Matthew

Nov 22, 2024: Grant or award of RGS shares (Form 4, code A).
Nov 5, 2024: Tax withholdings of RGS shares (2 lines, Form 4, code F).

Other insiders filing for REGIS CORP (RGS)

Zupfer Kersten Delores, Chief Financial Officer
MANSBACH MICHAEL JOSEPH, Director
Charters William, Director
Benacci Nancy Cunningham, Director
ANDREWS LOCKIE, Director
Alfano Andrew, Director

How to read Form 4 transaction codes